Thus, we propose that the model of FSHD molecular pathogenesis should be updated to incorporate PAX7 target gene repression as an important molecular mechanism and to refine current therapeutic strategies. The gene discussed is PAX7; the disease is facioscapulohumeral muscular dystrophy.